Redirect Notice
The previous page is sending you to
https://www.finanzen.ch/nachrichten/aktien/sandoz-anleger-in-kauflaune-sandoz-einigt-sich-in-patentstreit-mit-amgen-in-usa-wegen-denosumab-1033304037
.
If you do not want to visit that page, you can
return to the previous page
.